Nwachuku Amechi Ekeke
Transaction: 08/01/2026
BUY
Change
+800,000
Price
$1.98
Filing
08/03/2026
Type
BUY
OmniAb, Inc.
OABI • Biotechnology
$4.33
▼ -0.42 (-8.84%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$557.68M
Growth
0.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.08Healthy liquidity · 4.02Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:33 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.33
Change-8.84%
Shares Out128.79M
Market Cap$557.68M
Enterprise Value$524.60M
52W Range1.30 - 2.79
Beta1.17
P/E-12.60
P/S14.51
P/B2.14
P/FCF-24.02
EV/Sales13.65
Price$4.33
Change-8.84%
Shares Out128.79M
Market Cap$557.68M
Enterprise Value$524.60M
52W Range1.30 - 2.79
Beta1.17
P/E-12.60
P/S14.51
P/B2.14
P/FCF-24.02
EV/Sales13.65
EV/EBITDA-19.61
EV/FCF-22.59
Earnings Yield-7.94%
FCF Yield-4.16%
Dividend Yield0.00%
Gross Margin-18.17%
Oper. Margin-3.83%
Profit Margin-3.47%
Debt/Eq0.08
Current Ratio4.02
Quick Ratio4.02
Revenue 5Y0.49%
Target$4.00
Target Upside-7.62%
Target Median$4.00
Target Range4.00 - 4.00
Volume27.22K
Avg Volume704.72K
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.08Healthy liquidity · 4.02Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
100/100
Bullish
Bullish
9
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$4.00
Mean
$4.00
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
Nwachuku Amechi Ekeke
Transaction: 07/13/2026
OTHER
Change
0
Price
Not reported
Filing
07/13/2026
Type
OTHER
Love Steven
Transaction: 06/17/2026
SELL
Change
-20,000
Price
Not reported
Filing
06/18/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Nwachuku Amechi Ekeke | BUY | +800,000 | $1.98 | 08/01/2026 | 08/03/2026 |
| Nwachuku Amechi Ekeke | OTHER | 0 | Not reported | 07/13/2026 | 07/13/2026 |
| Love Steven | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Love Steven | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| Love Steven | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| HIGGINS JOHN L | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| HIGGINS JOHN L | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| HIGGINS JOHN L | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Gotwals Philip J | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Gotwals Philip J | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| Gotwals Philip J | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Crouse Steven C. | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Crouse Steven C. | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| Crouse Steven C. | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Cochran Jennifer R. | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Cochran Jennifer R. | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| Cochran Jennifer R. | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Bertozzi Carolyn R | SELL | -20,000 | Not reported | 06/17/2026 | 06/18/2026 |
| Bertozzi Carolyn R | BUY | +40,000 | $2.03 | 06/17/2026 | 06/18/2026 |
| Bertozzi Carolyn R | BUY | +20,000 | Not reported | 06/17/2026 | 06/18/2026 |